Veru Inc. VERU
NASDAQ VERU
$2.14 +0.02 (+0.94%)
At close: Nov 11, 2026 · 4:00 PM EST

Veru (VERU) EPS (Basic) (2009 - 2026)

Updated

Veru's EPS (Basic) came in at -$0.30 for fiscal Q3 2026 (quarter ended Jun 30, 2026), compared with -$0.50 a year earlier.

Analysis

Veru (VERU) EPS (Basic) (2009 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Veru reported EPS (Basic) of -$0.97; for FY2025 (ended Sep 30, 2025), it was -$1.07.

  • Going back by fiscal year, EPS (Basic) was -$2.80 in FY2024, -$10.96 in FY2023, -$10.49 in FY2022 and $0.97 in FY2021.
  • The five-year range for quarterly EPS (Basic) is -$5.15 (fiscal Q4 2022) to -$0.12 (fiscal Q2 2026).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Basic) (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 7.23
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 0.09
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 2.38
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 2.05
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 2.01
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 7.14
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 1.96
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 0.57
10 Veru 48.87 Mn -61.41 Mn - -0.30
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -0.30
Mar 31, 2026 -0.12
Dec 31, 2025 -0.26
Jun 30, 2025 -0.50
Mar 31, 2025 -0.54
Dec 31, 2024 -0.61
Jun 30, 2024 -0.75
Mar 31, 2024 -0.68
Dec 31, 2023 -0.82
Sep 30, 2023 -0.96
Jun 30, 2023 -1.42
Mar 31, 2023 -4.18
Dec 31, 2022 -4.81
Sep 30, 2022 -5.15
Jun 30, 2022 -2.77
Mar 31, 2022 -1.77
Dec 31, 2021 -0.80
Sep 30, 2021 -0.56
Jun 30, 2021 -0.34
Mar 31, 2021 -0.38
API Access

Veru EPS (Basic) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=eps-basic&ticker=VERU&period=max&api_key=YOUR_API_KEY